ALLO vs ED · rev $22.0K vs P/E 18, rev $15.26B
Allogene Therapeutics Inc (ALLO) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
ALLO currently screens at market cap $258.1M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the ALLO and ED stock pages for the full models.
Not investment advice.